MARKET

STIM

STIM

Neuronetics
NASDAQ

Real-time Quotes | Nasdaq Last Sale

13.38
+0.23
+1.75%
Opening 09:37 05/07 EDT
OPEN
13.14
PREV CLOSE
13.15
HIGH
13.58
LOW
13.14
VOLUME
13.44K
TURNOVER
--
52 WEEK HIGH
22.43
52 WEEK LOW
1.700
MARKET CAP
344.67M
P/E (TTM)
-12.1548
1D
5D
1M
3M
1Y
5Y
Neuronetics (NASDAQ:STIM) Has Debt But No Earnings; Should You Worry?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Simply Wall St. · 1d ago
Neuronetics (STIM) Soars 39.2%: Is Further Upside Left in the Stock?
Neuronetics (STIM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Zacks · 1d ago
Top Biotech Stocks To Watch In May
May 05, 2021 (StockMarket.com via COMTEX) -- Should Investors Be Watching These 4 Top Biotech Stocks Now? You can't deny that 2020 was a banner year for...
StockMarket.com · 1d ago
Neuronetics (STIM) Gets a Buy Rating from Canaccord Genuity
Canaccord Genuity analyst William Plovanic maintained a Buy rating on Neuronetics (STIM) yesterday and set a price target of $21.00. The company's shares
SmarterAnalyst · 2d ago
64 Biggest Movers From Yesterday
Gainers
Benzinga · 2d ago
10-Q: NEURONETICS, INC.
(EDGAR Online via COMTEX) -- Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations. The following discussion and...
Edgar Online - (EDG = 10Q, 10K) · 2d ago
Mid-Afternoon Market Update: Nasdaq Tumbles 300 Points; Neuronetics Shares Spike Higher
Toward the end of trading Tuesday, the Dow traded down 0.22% to 34,036.73 while the NASDAQ fell 2.2% to 13,589.88. The S&P also fell, dropping 1.06% to 4,148.42.
Benzinga · 2d ago
Why Cocrystal Pharma, Chemocentryx, Neuronetics And BioLineRx Are Moving Today
Cocrystal Pharma, Inc. (NASDAQ: COCP), ChemoCentryx, Inc. (NASDAQ: CCXI), Neuronetics, Inc.
Benzinga · 2d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of STIM. Analyze the recent business situations of Neuronetics through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 5 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average STIM stock price target is 21.50 with a high estimate of 23.00 and a low estimate of 21.00.
EPS
Institutional Holdings
Institutions: 116
Institutional Holdings: 19.15M
% Owned: 74.42%
Shares Outstanding: 25.76M
TypeInstitutionsShares
Increased
12
1.60M
New
15
2.56M
Decreased
21
1.61M
Sold Out
8
1.18M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+0.92%
Healthcare Equipment & Supplies
+0.79%
Key Executives
President/Chief Executive Officer/Director
Chris Thatcher
Non-Executive Chairman/Independent Director
Brian Farley
President/Chief Executive Officer/Director
Keith Sullivan
Chief Financial Officer/Vice President
Stephen Furlong
Senior Vice President/Chief Compliance Officer/General Counsel/Secretary
W. Andrew Macan
Vice President/Director of Sales
Sara Grubbs
Vice President
Cory Anderson
Vice President
Yelena Tropsha
Other
Daniel Guthrie
Director
John Bakewell
Independent Director
Robert Cascella
Independent Director
Sheryl Conley
Independent Director
Wilfred Jaeger
Independent Director
Glenn Muir
Independent Director
Bruce Shook
No Data
About STIM
Neuronetics, Inc. is commercial-stage medical technology company. The Company is focused on the design and development of medical devices to treat psychiatric disorders. The Company’s principal product is NeuroStar Advanced Therapy System. It is a non-invasive treatment that uses transcranial magnetic stimulation (TMS) to create a pulsed magnetic field to induce electrical pulses for stimulating certain areas of the brain associated with mood. The system is used to treat adult patients with major depressive disorders. The Company offers its therapy systems to psychiatrist offices in the United States.

Webull offers kinds of Neuronetics Inc stock information, including NASDAQ:STIM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, STIM stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading STIM stock methods without spending real money on the virtual paper trading platform.